Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

This study is offering children with acute lymphoblastic leukemia (ALL) — the most common childhood cancer — standardized, evidence-based treatment through the GFAOP (a pediatric oncology group in French-speaking Africa). It aims to improve survival outcomes by ensuring children receive consistent, guideline-based care. **You may be eligible if...** - You are a child between 0 and 18 years old - You have a newly diagnosed ALL (first diagnosis) - You have not yet received any chemotherapy for ALL - Your leukemia is of the FAB L1 or L2 type **You may NOT be eligible if...** - You have ALL type L3 (Burkitt lymphoma/leukemia), which requires a different treatment - You have already received chemotherapy for this leukemia - You have Down syndrome (Trisomy 21) Talk to your doctor to see if this trial is right for you.